Just Biotherapeutics Secures $14,000,000 Series A Funding

  • Feed Type
  • Date
    7/26/2016
  • Company Name
    Just Biotherapeutics
  • Mailing Address
    401 Terry Avenue North Seattle, WA 98109 USA
  • Company Description
    Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. We believe that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.
  • Website
    http://www.justbiotherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The proceeds will support the completion of new lab space, pilot plant and GMP capabilities that will enable Just to accelerate the development of lower-cost biologics.
  • M&A Terms
  • Venture Investor
    Bill & Melinda Gates Foundation
  • Venture Investor
    Merck Capital Ventures
  • Venture Investor
    Lilly Asia Ventures
  • Venture Investor
    ARCH Venture Partners

Trending on Xconomy